Vyne Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.65

+0.00 (+0.00%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +2,898.5% upside

Low Target $14.75

Average Target $19.49

High Target $26.42

Current Price $0.65

Current
$0.65

Target
$19.49

$14.75 $19.49 avg $26.42

Scenario Analysis

Bear Case

$14.75

2,169.2%

Low target

Base Case

$19.49

+2,898.5%

Avg target

Bull Case

$26.42

+3,964.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.96

-66.8% from high

52-Week Low

$0.28

+131.7% from low

Target vs 52W High

$19.49

+894.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%